Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children

نویسندگان
doi
چکیده

Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and radiation. The current challenge is to determine how much therapy is needed to improve survival and how to adapt ...

کلیدواژه‌ها